Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum

Milà‐Alomà, Marta, Salvadó, Gemma, Gispert, Juan Domingo, Vilor‐Tejedor, Natalia, Grau‐Rivera, Oriol, Sala‐Vila, Aleix, Sánchez‐Benavides, Gonzalo, Arenaza‐Urquijo, Eider M., Crous‐Bou, Marta, González‐de‐Echávarri, José Maria, Minguillon, Carolina, Fauria, Karine, Simon, Maryline, Kollmorgen, Gwendlyn, Zetterberg, Henrik, Blennow, Kaj, Suárez‐Calvet, Marc, Molinuevo, José Luis, for the ALFA study·2020·Alzheimer's & Dementia

Cited by (241)

Items 101–200 of 241

  1. Time‐encoded ASL reveals lower cerebral blood flow in the early AD continuum
    Carles Falcón, Paula Montesinos, Lena Václavů, Michalis Kassinopoulos, Carolina Minguillón, Karine Fauria, Diego Cascales‐Lahoz, José Contador, Aida Fernández‐Lebrero, Irene Navalpotro‐Gómez et al. · 2024 · Alzheimer s & Dementia
  2. Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer’s Disease Cerebrospinal Fluid Biomarker Levels
    Anna Brugulat‐Serrat, for the ALFA study, Alba Cañas, Lidia Canals‐Gispert, Paula Marne, Nina Gramunt, Marta Milà‐Alomà, Marc Suárez‐Calvet, Eider M. Arenaza‐Urquijo, Oriol Grau‐Rivera et al. · 2021 · Journal of Alzheimer s Disease
  3. Amyloid precursor protein in Alzheimer's disease
    Rupesh Maurya, Gargi Bhattacharjee, Khushal Khambhati, Nisarg Gohil, Priyanka Singh, Indra Mani, Dinh‐Toi Chu, Suresh Ramakrishna, Pau-Loke Show, Vijai Singh · 2022 · Progress in molecular biology and translational science
  4. Associations between objective sleep metrics and brain structure in cognitively unimpaired adults: interactions with sex and Alzheimer's biomarkers
    Laura S Stankeviciute, Núria Tort‐Colet, Ana Fernández‐Arcos, Gonzalo Sánchez‐Benavides, Carolina Minguillón, Karine Fauria, Sebastian C. Holst, Pilar Garcés, Thomas Mueggler, Henrik Zetterberg et al. · 2025 · Alzheimer s & Dementia
  5. Research trends and hotspots of glial fibrillary acidic protein within the area of Alzheimer’s disease: a bibliometric analysis
    Yutong Zou, Lei Li, Lihua Guan, Chaochao Ma, Songlin Yu, Xiaoli Ma, Chenhui Mao, Jing Gao, Ling Qiu · 2023 · Frontiers in Aging Neuroscience
  6. Cerebrospinal fluid β2-microglobulin promotes the tau pathology through microglia–astrocyte communication in Alzheimer's disease
    Ze-Hu Sheng, Lanyang Wang, Ming Chen, Fuxin Zhong, Shijing Wu, Shuyu Liang, Jiaqi Song, Lihua Chen, Yingxi Chen, Shiyu Chen et al. · 2025 · Alzheimer s Research & Therapy
  7. Neuroprotection beyond neurons: integrated biomarker-based and astroglia- or microglia-targeted approaches to combat neurodegenerative diseases
    Cinzia Volonté, Guoku Hu, Christopher A. Shaw, Viegas Junior Claudio, Joyce Alves dos Santos, Sandra Henriques Vaz, Ana Morais Sebastião, Vladimír J. Balcar, P. David Mozley, Federico Verde et al. · 2026 · Exploration of Neuroprotective Therapy
  8. CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment
    Siddhant Tripathi, Yashika Sharma, Rajesh A. Rane, Dileep Kumar · 2024 · CNS & Neurological Disorders - Drug Targets
  9. Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
    Anna L. Svenningsson, Diana I. Bocancea, Erik Stomrud, Anita C. van Loenhoud, Frederik Barkhof, Niklas Mattsson, Sebastian Palmqvist, Oskar Hansson, Rik Ossenkoppele · 2024 · Alzheimer s Research & Therapy
  10. Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p‐tau in the earliest Alzheimer's continuum : Evidence across two independent cohorts
    Raffaele Cacciaglia, Carles Falcón, Gonzalo Sánchez‐Benavides, Anna Brugulat‐Serrat, Marta Milà Alomà, Marc Suárez‐Calvet, José Luís Molinuevo, Karine Fauria, Carolina Minguillón, Gwendlyn Kollmorgen et al. · 2025 · Alzheimer s & Dementia
  11. Prepandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults
    Müge Akinci, Cleofé Peña-Gómez, Grégory Operto, Sherezade Fuentes‐Julián, Carme Deulofeu, Gonzalo Sánchez‐Benavides, Marta Milà‐Alomà, Oriol Grau‐Rivera, Nina Gramunt, Arcadi Navarro et al. · 2022 · Neurology
  12. Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
    Caterina Motta, Martina Gaia Di Donna, Chiara Giuseppina Bonomi, Martina Assogna, Agostino Chiaravalloti, Nicola Biagio Mercuri, Giacomo Koch, Alessandro Martorana · 2023 · Alzheimer s Research & Therapy
  13. The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer’s Disease Pathology
    Malin Wennström, Nina Schultz, Paula Mille Gallardo, The Netherlands Brain Bank, Geidy E. Serrano, Thomas G. Beach, Suchira Bose, Oskar Hansson · 2024 · Cells
  14. The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer’s disease
    Raffaele Cacciaglia, Mahnaz Shekari, Gemma Salvadó, Marta Milà‐Alomà, Carles Falcón, Gonzalo Sánchez‐Benavides, Carolina Minguillón, Karine Fauria, Oriol Grau‐Rivera, José Luís Molinuevo et al. · 2024 · Brain Communications
  15. Integrated Dual Analysis of Quantitative and Qualitative High-Dimensional Data
    Juliane Müller, Laura Garrison, Philipp Arndt, Stefanie Schreiber, Stefan Brückner, Helwig Hauser, Steffen Oeltze‐Jafra · 2021 · IEEE Transactions on Visualization and Computer Graphics
  16. Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer’s Disease
    Fangda Leng, on behalf of Alzheimer’s Disease Neuroimaging Initiative, Zhenying Zhan, Yunchuang Sun, Fang Liu, Paul Edison, Yongan Sun, Zhaoxia Wang · 2022 · Journal of Alzheimer s Disease
  17. A Practical Approach for the Detection of Protein Tau with a Portable Potentiostat
    Münteha Nur Sonuç Karaboğa, Mustafa Kemal Sezgintürk · 2022 · Electroanalysis
  18. Identification of the molecular subgroups in Alzheimer's disease by transcriptomic data
    He Li, Meiqi Wei, Tianyuan Ye, Yiduan Liu, Dongmei Qi, Xiaorui Cheng · 2022 · Frontiers in Neurology
  19. Blood pressure and Alzheimer’s disease biomarkers in cognitively unimpaired adults: a multicenter study
    Osset-Malla, Mariona, Martínez-Velasco, Aitana, Sánchez-Benavides, Gonzalo, Buongiorno, Mariateresa, de la Sierra, Alejandro, Shekari, Mahnaz, Minguillon, Carolina, Kollmorgen, Gwendlyn, Quijano-Rubio, Clara, Zetterberg, Henrik et al. · 2025 · The Journal of Prevention of Alzheimer's Disease
  20. 14-3-3 $$\upzeta /\updelta$$-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2
    Marcel S. Woo, Johanna Nilsson, Joseph Therriault, Nesrine Rahmouni, Ann Brinkmalm, Andréa Lessa Benedet, Nicholas James Ashton, Arthur C. Macedo, Stijn Servaes, Yi-Ting Wang et al. · 2023 · Journal of Neuroinflammation
  21. Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer’s disease
    Argiris, Georgette, Akinci, Muge, Peña-Gómez, Cleofé, Palpatzis, Eleni, Garcia-Prat, Marina, Shekari, Mahnaz, Blennow, Kaj, Zetterberg, Henrik, Kollmorgen, Gwendlyn, Quijano-Rubio, Clara et al. · 2024 · Alzheimer's Research & Therapy
  22. A Review of CRISPR Cas9 for Alzheimer’s Disease: Treatment Strategies and Could target APOE e4, APP, and PSEN-1 Gene using CRISPR cas9 Prevent the Patient from Alzheimer’s Disease?
    Arga Setyo Adji, Jordan Steven Widjaja, Vira Aulia Kusuma Wardani, Alvian Habib Muhammad, Fitri Handajani, Hendy Bhaskara Perdana Putra, Firman Suryadi Rahman · 2022 · Open Access Macedonian Journal of Medical Sciences
  23. Atypical cortical hierarchy in Aβ-positive older adults and its reflection in spontaneous speech
    Rui He, Jalal Al‐Tamimi, Gonzalo Sánchez‐Benavides, Guillermo Montaña-Valverde, Juan Domingo Gispert, Oriol Grau‐Rivera, Marc Suárez‐Calvet, Carolina Minguillón, Karine Fauria, Arcadi Navarro et al. · 2024 · Brain Research
  24. Plasma Biomarkers in the Distinction of Alzheimer’s Disease and Frontotemporal Dementia
    Estrella Gómez‐Tortosa, Pablo Agüero, Alicia Ruiz-González, Sonia Wagner, Raquel Téllez, Ignacio Mahíllo, Andrea Ruiz-Calvo, María José Sainz, Anna Lena Nystrom, Teodoro del Ser et al. · 2025 · International Journal of Molecular Sciences
  25. Neuroimaging-derived biological brain age and its associations with glial reactivity and synaptic dysfunction cerebrospinal fluid biomarkers
    Irene Cumplido‐Mayoral, Gonzalo Sánchez‐Benavides, Natàlia Vilor‐Tejedor, David López‐Martos, Anna Brugulat‐Serrat, Marta Milà‐Alomà, Carles Falcón, Raffaele Cacciaglia, Carolina Minguillón, Karine Fauria et al. · 2025 · Molecular Psychiatry
  26. Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study
    Mariana I. Muñoz-García, Yuetiva K. Deming, Ferran Lugo-Hernández, Sterling C. Johnson, Sanjay Asthana, Gwendlyn Kollmorgen, Clara Quijano‐Rubio, Cynthia M. Carlsson, Ozioma C. Okonkwo, David Andrés Pérez-Martínez et al. · 2025 · Molecular Neurodegeneration
  27. Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease
    David López‐Martos, Marc Suárez‐Calvet, Marta Milà‐Alomà, Juan Domingo Gispert, Gemma Salvadó, Anna Brugulat‐Serrat, Mahnaz Shekari, Carolina Minguillón, Henrik Zetterberg, Kaj Blennow et al. · 2025 · Neurology
  28. Sex differences in Alzheimer’s disease CSF biomarkers and their association with Aβ pathology on PET in cognitively unimpaired individuals
    Marta Milà‐Alomà, Carol Van Hulle, Anna Brugulat‐Serrat, Margot M Casals Brodu, Armand González‐Escalante, Gonzalo Sánchez‐Benavides, Mahnaz Shekari, Laura Castro‐Aldrete, Carolina Minguillón, J Martínková et al. · 2025 · Alzheimer s Research & Therapy
  29. Soluble TREM2 in body fluid in Alzheimer’s disease and Parkinson’s disease
    Lihua Gu, Hao Shu, Yanjuan Wang · 2023 · Neurological Sciences
  30. Non-invasive biomarkers for brain aging: the role of autophagy-related microRNAs in plasma exosomes
    Qian Cheng, Shuyi Yu, Zhuang Cui, Hang Chen, Jing Fan, Qian Yu, Yan Jin, Yunshan Wang, Min Li, Zhiming Lu · 2025 · Frontiers in Molecular Neuroscience
  31. Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis
    Alessandro Padovani, Antonio Canale, Lorenzo Schiavon, Stefano Masciocchi, Alberto Imarisio, Barbara Risi, Giulio Bonzi, Valeria De Giuli, Mónica Di Luca, Nicholas James Ashton et al. · 2022 · Alzheimer s & Dementia
  32. Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis – a prospective follow-up study
    Ivar Tjernberg, Paula Gyllemark, Henrik Zetterberg, Kaj Blennow, Jan Ernerudh, Pia Forsberg, Johanna Sjöwall, Anna Jonsson Henningsson · 2022 · Clinical Chemistry and Laboratory Medicine (CCLM)
  33. Diagnostic Cut-offs for CSF β-amyloid and tau proteins in a Danish dementia clinic
    Anders Mønsted Abildgaard, Tina Parkner, Cindy Soendersoe Knudsen, Hanne Gottrup, Henriette Klit · 2022 · Clinica Chimica Acta
  34. Ion transporter cascade, reactive astrogliosis and cerebrovascular diseases
    Md Shamim Rahman, Rabia Islam, Mohammad Iqbal H. Bhuiyan · 2024 · Frontiers in Pharmacology
  35. Grief and Economic Stressors by Sex, Gender, and Education
    Eleni Palpatzis, Muge Akinci, Marina García-Prat, K. Blennow, H. Zetterberg, C. Quijano-Rubio, G. Kollmorgen, N. Wild, J. Gispert, M. Suárez-Calvet et al. · 2025 · Neurology
  36. Associations between fluid biomarkers and PET imaging ([11C]UCB‐J) of synaptic pathology in Alzheimer's disease
    Johanna Nilsson, Adam P. Mecca, Nicholas James Ashton, Elaheh Salardini, Ryan S. O’Dell, Richard E. Carson, Andréa Lessa Benedet, Kaj Blennow, Henrik Zetterberg, Christopher H. van Dyck et al. · 2025 · Alzheimer s & Dementia
  37. Entorhinal cortex astrocytic atrophy in human frontotemporal dementia
    Jose Julio Rodriguez, F. Zallo, Emanuela Gardenal, Joan Cabot, X. Busquets · 2024 · Brain Structure and Function
  38. Autocorrection if→of function words in reading aloud: A novel marker of Alzheimer’s risk.
    Tamar H. Gollan, Alena Stasenko, Chuchu Li, Denis S. Smirnov, Douglas R Galasko, David P. Salmon · 2022 · Neuropsychology
  39. Association between serum urate and CSF markers of Alzheimer's disease pathology in a population‐based sample of 70‐year‐olds
    Tahzeeb Fatima, L. Jacobsson, Silke Kern, Anna Zettergren, Kaj Blennow, Henrik Zetterberg, Lena Havstam Johansson, Mats Dehlin, Ingmar Gr. Skoog · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  40. Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
    João Pedro Ferrari‐Souza, Pâmela C.L. Ferreira, Bruna Bellaver, Cécile Tissot, Yi-Ting Wang, Douglas Teixeira Leffa, Wagner Scheeren Brum, Andréa Lessa Benedet, Nicholas James Ashton, Marco Antônio De Bastiani et al. · 2022 · medRxiv
  41. Specific associations between plasma biomarkers and post-mortem amyloid plaque and neurofibrillary tau tangle loads
    Gemma Salvadó, Rik Ossenkoppele, Nicholas James Ashton, Thomas G. Beach, Geidy E. Serrano, Henrik Zetterberg, Niklas Mattsson, Shorena Janelidze, Kaj Blennow, Oskar Hansson · 2022 · medRxiv
  42. Relationships of PGRN with sTREM2 in AD continuum and non-AD pathophysiology and their reciprocal roles in modulating amyloid pathology: two population-based study
    Liangyu Huang, Chen‐Chen Tan, Wei Xu, Lan Tan, Alzheimer’s Disease Neuroimaging Initiative, Michael Walter Weiner, Paul S. S Aisen, Ronald Carl Petersen, Clifford R. Jack, William Jagust et al. · 2025 · Translational Psychiatry
  43. Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia
    Iolanda Lázaro, Oriol Grau‐Rivera, Marc Suárez‐Calvet, Karine Fauria, Carolina Minguillón, Mahnaz Shekari, Carles Falcón, Marina García-Prat, Jordi Huguet, José Luís Molinuevo et al. · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  44. Exploring cognitive and biological correlates of sleep quality and their potential links with Alzheimer’s disease (ALFASleep project): protocol for an observational study
    Karine Fauria, Carolina Minguillón, Iva Knezevic, Núria Tort‐Colet, Laura S Stankeviciute, Laura Hernández, Andreea Rădoi, Carme Deulofeu, Sherezade Fuentes‐Julián, Israel Turull et al. · 2022 · BMJ Open
  45. Biomarkers of diagnosis, prognosis, pathogenesis, response to therapy: Convergence or divergence? Lessons from Alzheimer's disease and synucleinopathies
    Stefano Luca Sensi, Mirella Russo, Pietro Tiraboschi · 2023 · Handbook of clinical neurology
  46. Compositional brain scores capture Alzheimer's disease–specific structural brain patterns along the disease continuum
    Patricia Genius, M. Luz Calle, Blanca Rodríguez‐Fernández, Carolina Minguillón, Raffaele Cacciaglia, Diego Garrido-Martín, Manel Esteller, Arcadi Navarro, Juan Domingo Gispert, Natàlia Vilor‐Tejedor et al. · 2025 · Alzheimer s & Dementia
  47. Sleep-related changes in astrocytic biomarkers are modulated by APOE ε4 genotype in cognitively unimpaired adults
    Nuole Zhu, Miren Altuna, Javier Arranz, Íñigo Rodríguez‐Baz, María Belén Sánchez‐Saudinós, Laura Videla, Sílvia Valldeneu, Mireia Carrera-Vega, Sergio Romero, Juan Fortea et al. · 2025 · Brain Communications
  48. Use of modern classification systems for complex diagnostics of Alzheimer’s disease
    Yana Zorkina, Irina Morozova, Olga V. Abramova, Aleksandra Ochneva, O A Gankina, A. V. Andryushenko, M V Kurmyshev, Georgiy P. Kostyuk, Anna Y. Morozova · 2024 · S S Korsakov Journal of Neurology and Psychiatry
  49. CSF Aβ40 Levels Do Not Correlate with the Clinical Manifestations of Alzheimer’s Disease
    Jesús García Castro, Helena Méndez del Sol, Olaia Rodríguez Fraga, María Hernández-Barral, Soledad Serrano-López, Ana Frank García, Ángel Martín Montes · 2022 · Neurodegenerative Diseases
  50. “Proteinjury”: a universal pathological mechanism mediated by cerebrospinal fluid in neurodegeneration and trauma
    Vladimir F. Lazarev, Bashar A. Alhasan, Irina V. Guzhova, Boris A. Margulis · 2025 · Frontiers in Cell and Developmental Biology
  51. Reference Data for Attentional, Executive, Linguistic, and Visual Processing Tests Obtained from Cognitively Healthy Individuals with Normal Alzheimer’s Disease Cerebrospinal Fluid Biomarker Levels
    David López‐Martos, Anna Brugulat‐Serrat, Alba Cañas, Lidia Canals‐Gispert, Paula Marne, Nina Gramunt, Marc Suárez‐Calvet, Marta Milà‐Alomà, Carolina Minguillón, Karine Fauria et al. · 2023 · Journal of Alzheimer s Disease
  52. Relationship between baseline plasma p‐tau181 and longitudinal changes in cognition and structural brain measures in a cohort of cognitively unimpaired older adults
    Marcos Vasconcelos Pais, Chia‐Ling Kuo, Beau M. Ances, Julie Loebach Wetherell, Eric J. Lenze, Breno Satler Diniz · 2023 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  53. Fluid Biomarkers in Clinical Trials for Alzheimer’s Disease: Current and Future Application
    Jianwei Yang, Longfei Jia, Yan Li, Qiongqiong Qiu, Meina Quan, Jianping Jia · 2021 · Journal of Alzheimer s Disease
  54. Altered structural-functional coupling in Parkinson’s disease
    Zhichun Chen, Guanglu Li, Liche Zhou, Lina Zhang, Jun Liu · 2023 · medRxiv
  55. A multiscale model to explain the spatiotemporal progression of amyloid beta and tau pathology in Alzheimer's disease
    Chunrui Xu, Enze Xu, Yang Xiao, Defu Yang, Guorong Wu A, Minghan Chen · 2025 · International Journal of Biological Macromolecules
  56. Comparison of CSF neurofilament light chain and total tau as neurodegeneration markers: Associations with synaptic markers and cognitive outcomes
    Grit Richter, Bjørn‐Eivind Kirsebom, Jonas Alexander Jarholm, Lene Pålhaugen, Berglind Gísladóttir, Dag Aarsland, Gøril Rolfseng Grøntvedt, Ragnhild Eide Skogseth, Knut K. Waterloo, Tormod Fladby et al. · 2025 · Neurobiology of Aging
  57. Plasma p-tau212 identifies cognitively unimpaired individuals with emerging amyloid-β pathology
    Przemysław Radosław Kac, Armand González‐Escalante, Marta Milà‐Alomà, Nicholas James Ashton, Mahnaz Shekari, Paula Ortiz‐Romero, Michael Turton, Peter Harrison, Henrik Zetterberg, Juan Domingo Gispert et al. · 2025 · Journal of Neurology
  58. Cerebrospinal Fluid CCL25 as a Biomarker for Alzheimer's Disease: Associations with Pathology, Neurodegeneration, and Cognitive Decline
    Yuhan Chen, Zhibo Wang, Xipeng Liu, Zhiqi Mao, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Molecular Neurobiology
  59. Proteomic polygenic risk scores of age-related plasma protein levels reveal a role for Metalloproteinase inhibitor 2 (TIMP2) in cognitive performance
    Federica Anastasi, Patricia Genius, Blanca Rodríguez‐Fernández, Chengran Yang, Priyanka Gorijala, Jigyasha Timsina, Luis Felipe Hernández‐Villamizar, Luigi Lorenzini, Marta del Campo, Gonzalo Sánchez‐Benavides et al. · 2025 · Neurobiology of Aging
  60. Novel Computer-Aided Diagnosis System for the Early Detection of Alzheimer’s Disease
    Meshal Alharbi, Shabana R. Ziyad · 2022 · Computers, materials & continua/Computers, materials & continua (Print)
  61. Cerebrospinal fluid YKL‐40 level evolution is associated with autoimmune encephalitis remission
    Guillaume Dorcet, Marie Bénaiteau, Jérémie Pariente, Fabienne Ory‐Magne, Emmanuel Cheuret, Marie Rafiq, Wesley H. Brooks, Bénédicte Puissant‐Lubrano, Françoise Fortenfant, Yves Renaudineau et al. · 2023 · Clinical & Translational Immunology
  62. High Blood Pressure and Impaired Brain Health: Investigating the Neuroprotective Potential of Magnesium
    Khawlah Alateeq, Erin Walsh, Nicolas Cherbuin · 2024 · International Journal of Molecular Sciences
  63. The Potential Role of Neurogranin in Alzheimer’s Disease
    Xin Zhou, Xiao-jun Jing, Hua Zhang · 2025 · Journal of Integrative Neuroscience
  64. Sex-specific neuroinflammatory responses to air pollution mediates cognitive performance in cognitively unimpaired individuals at risk of Alzheimer’s dementia
    Natàlia Vilor‐Tejedor, Blanca Rodríguez‐Fernández, Patricia Genius, Alba Fernández-Bonet, Armand González‐Escalante, Anna Brugulat‐Serrat, Gonzalo Sánchez‐Benavides, Irene Cumplido‐Mayoral, Carolina Minguillón, Marta Cirach et al. · 2024 · medRxiv
  65. Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias
    Giovanni Bellomo, Lisa Vermunt, Sjors G. J. G. In ‘t Veld, James D. Doecke, Yanaika S. Hok‐A‐Hin, Kateřina Veverová, Isabel Houtkamp, Daniel Andres Alcolea, Steffen Halbgebauer, Carlos Quesada et al. · 2026 · Nature Aging
  66. Fluid Markers of Alzheimer Disease
    Courtney L. Sutphen, Katherine Volluz, Rawan M. Tarawneh · 2025 · Springer eBooks
  67. Longitudinal association of shorter leukocyte telomere length with CSF biomarker dynamics across early Alzheimer's disease stages in at-risk individuals
    Blanca Rodríguez‐Fernández, Armand González‐Escalante, Patricia Genius, Tavia E. Evans, Pablo Luis Ortiz-Romero, Carolina Minguillón, Gwendlyn Kollmorgen, Nicholas James Ashton, Henrik Zetterberg, Kaj Blennow et al. · 2025 · EBioMedicine
  68. Olfactory dysfunction and amyloid-positivity in Parkinson’s disease—longitudinal analysis of cognitive decline and cerebrospinal fluid markers
    Victoria Larsson, Sara Hall, Kaj Blennow, Oskar Hansson · 2025 · PLoS ONE
  69. Red blood cell ω-3 status and longitudinal cognition in individuals at risk of Alzheimer disease
    Iolanda Lázaro, Anna Brugulat‐Serrat, Marc Suárez‐Calvet, Karine Fauria, Carolina Minguillón, Juan Domingo Gispert, José Luís Molinuevo, William S Harris, Gonzalo Sánchez‐Benavides, Oriol Grau‐Rivera et al. · 2025 · Journal of Nutrition
  70. Speech‐based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts
    Alexandra König, Johannes Tröger, Elisa Mallick, Nicklas Linz, Craig William Ritchie, Sarah Gregory, Matthew B. Hunter, Kay Johnson, Gonzalo Sánchez‐Benavides, Oriol Grau‐Rivera et al. · 2026 · Alzheimer s & Dementia
  71. Multimodal biomarker characterization of amnestic objective subtle cognitive decline in aging and preclinical Alzheimer’s disease
    David López‐Martos, Raffaele Cacciaglia, Marc Suárez‐Calvet, Gemma Salvadó, Mahnaz Shekari, Armand González‐Escalante, Marta Milà‐Alomà, Anna Brugulat‐Serrat, Carolina Minguillón, Mattéo Tonietto et al. · 2026 · The Journal of Prevention of Alzheimer s Disease
  72. Parallel neuroinflammatory pathways to cerebrovascular burden and amyloid beta in Alzheimer's disease
    Batool M. Rizvi, Jenna N. Adams, Alison R. Bamford, Soyun Kim, Mithra T. Sathishkumar, Nicholas James Tustison, Lisa Taylor, Nandita Tuteja, Liv C. McMillan, Bin Nan et al. · 2026 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  73. Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson’s Disease Following Concussive Head Injury
    Lianyuan Feng, Aruna Sharma, Zhenguo Wang, Dafin Fior Muresanu, Z. Ryan Tian, José Vicente Lafuente, Anca Dana Buzoianu, Ala Nozari, Lars Wiklund, Hari Shanker Sharma · 2023 · Advances in neurobiology
  74. Innovative Discoveries in Neurosurgical Treatment of Neurodegenerative Diseases: A Narrative Review
    Matthew C. Findlay, Majid Khan, Mrinmoy Kundu, Chase M. Johansen, Brandon Peter Lucke-Wold · 2023 · Current Alzheimer Research
  75. ACOT7, a candidate and novel serum biomarker of Alzheimer’s disease
    Jintao Wang, Yong Feng, Yingni Sun · 2024 · Frontiers in Aging Neuroscience
  76. Polygenic hazard score predicts synaptic and axonal degeneration and cognitive decline in Alzheimer's disease continuum
    Mohammad‐Erfan Farhadieh, Mehrdad Mozafar, Saameh Sanaaee, Parastoo Sodeifi, Kiana Kousha, Yeganeh Zare, Shahab Zare, Nooshin Maleki Rad, Faezeh Jamshidi Goharrizi, Mohammad Allahverdloo et al. · 2024 · Archives of Gerontology and Geriatrics
  77. Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Aß
    V. Matafora, Alena Gorb, Wendy Noble, A. Bachi, B. Perez-Nievas, Maria Jimenez-Sanchez · 2023 · bioRxiv
  78. Polygenic proxies of age-related plasma protein levels reveal TIMP2 role in cognitive performance
    Federica Anastasi, Patricia Genius, Blanca Rodríguez‐Fernández, Chengran Yang, Priyanka Gorijala, Jigyasha Timsina, Luis Felipe Hernández‐Villamizar, Luigi Lorenzini, Marta del Campo, Gonzalo Sánchez‐Benavides et al. · 2024 · medRxiv
  79. The fluid biomarkers of Alzheimer’s disease
    Qinyu Peng, Zhentao Zhang · 2021 · Brain Science Advances
  80. Biomarcadores de la enfermedad de Alzheimer encontrados en pacientes con diabetes mellitus tipo 2: correlación entre ambas patologías
    Miguel Alejandro Walwyn-Hernández, Luis Ignacio Cepeda-Morales, Oscar Mateos-Platas, Eduardo Cantú-Flores · 2023 · Archives of Evidence-Based Medicine
  81. Large-scale plasma proteomic analysis identifies pathophysiological mechanisms and predictive biomarkers for cardiac arrest
    Ning Wang, Yan Guo, Songlin Lu, Chen Sun, Chang Wang, Qinduo Ren, Yuan Xu, Qinghua Liu, Jingyang Hu, Chi Yan et al. · 2026 · Resuscitation
  82. Association of Alzheimer’s disease progression with YKL40 levels in peripheral blood and cerebrospinal fluid: a systematic review and meta-analysis
    Qianwen Yang, Ruiqi Wang, Jian Pei, Qinhui Fu, Yijun Zhan, Wenyan ZHU · 2026 · Frontiers in Neurology
  83. Sex-specific early cognitive changes are linked to global and pathway-specific genetic risk for Alzheimer’s disease in at-risk individuals
    Patricia Genius, Alba Fernández-Bonet, Blanca Rodríguez‐Fernández, Clara Gallay, Armand Gonzalez-Escalante, Gonzalo Sánchez‐Benavides, David López‐Martos, Manel Esteller, Arcadi Navarro, Juan Domingo Gispert et al. · 2026 · Biology of Sex Differences
  84. Intracellular fluid accumulation underlies brain volume increases in early Alzheimer’s disease
    Michalis Kassinopoulos, Paula Montesinos, Carles Falcón, Jordi Huguet, Carolina Minguillón, Karine Fauria, Gwendlyn Kollmorgen, Clara Quijano‐Rubio, José Luís Molinuevo, Oriol Grau‐Rivera et al. · 2026 · Brain Communications
  85. Large-scale proteomic analyses before depression diagnosis reveal novel pathophysiological insights
    Bolun Cheng, Shiqiang Cheng, Chuyu Pan, Wenming Wei, Jin Feng, Xin Qi, Boyue Zhao, Yan Wen, Feng Zhang · 2026 · Molecular Psychiatry
  86. Simultaneous Profiling and Quantification of Tau and Its Phosphorylated Isomers Using Engineered FraC Nanopores
    Yu Xin, Defu Liu, Ma Yk, Zhijing Zhang, Peng Chen, Mengze Wu, Yue Li, Shanchuan Chen, Shixin Yan, Guiqin Song et al. · 2026 · Nano Letters
  87. Peripheral biomarkers of neuroinflammation in Alzheimer’s disease and vascular dementia
    Xiaoxue Ouyang, Rachel S.L. Chia, Yuek Ling Chai, Chong, Ming Ann Sim, Dong‐Gyu Jo, Thiruma Valavan Arumugam, Gautam Sethi, Gavin Stewart Dawe, Christopher P. Chen et al. · 2026 · Biochemical Pharmacology
  88. FOXO transcription factors in Alzheimer’s Disease: balancing neuroprotection and neuronal degeneration
    Mukul Shyam, Aleen Veronica, Jyoti Wadhwa, Vidhi Sharma, Oveyaa Bm, Prathap Srirangan, Rajendran Venkatesh, Sabina Evan Prince · 2026 · Molecular Biology Reports
  89. Plasmonic nanoplatforms for Alzheimer’s disease biomarker detection: LSPR and SERS strategies toward clinical translation
    Hyejin Chang, Homan Kang, Seung-Ki Lee, Jaehong Lim, Ksenia V. Kastanenka, Satoshi Kashiwagi, Bong‐Hyun Jun · 2026 · Materials Today
  90. Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer’s disease and a history of traumatic brain injury
    Suzan van Amerongen, Shreyasee Das, Suzie Kamps, Julie Goossens, Bram Bongers, Yolande A.L. Pijnenburg, Eugeen Vanmechelen, Everard G.B. Vijverberg, Charlotte Elisabeth Teunissen, Inge M.W. Verberk · 2024 · Neurobiology of Aging
  91. The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people
    Tovia Jacobs, Sean R. Jacobson, Juan Fortea, Jeffrey S. Berger, Alok Vedvyas, Karyn Marsh, Tianshe He, Eugenio Gutiérrez‐Jiménez, Nathanael R. Fillmore, Omonigho M. Bubu et al. · 2024 · Research Square
  92. Sex-specific associations between astrocytic reactivity and cognitive decline in unimpaired elderly
    Chelsea Reichert Plaska, Tovia Jacobs, Davide Bruno, Sang Han Lee, Bruno Pietro Imbimbo, Ricardo Osorio, Andréa Lessa Benedet, Nicholas James Ashton, Henrik Zetterberg, Nunzio Pomara et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Probable Novel APP Met671Leu Mutation in a Chinese Han Family with Early-Onset Alzheimer’s Disease
    Limin Ma, Fengyu Wang, Shuai Chen, Shenghui Wang, Zhenzhen Wang, Mingrong Xia, Yongli Li, Huimin Ma, Junkui Shang, Jiewen Zhang · 2024 · NeuroMolecular Medicine
  94. Compositional structural brain signatures capture Alzheimer’s genetic risk on brain structure along the disease continuum
    Patricia Genius, M. Luz Calle, Blanca Rodríguez‐Fernández, Carolina Minguillón, Raffaele Cacciaglia, Diego Garrido-Martín, Manel Esteller, Arcadi Navarro, Juan Domingo Gispert, Natàlia Vilor‐Tejedor et al. · 2024 · medRxiv
  95. INTERRELAÇÃO ENTRE A DOENÇA PERIODONTAL E DO ALZHEIMER: REVISÃO INTEGRATIVA
    Stefany Oliveira Leite, Gustavo Freire Batista, Vanessa Barbosa Magalhães, Aline Kelen Araújo Oliveira, Karina Sarno Paes Alves Dias · 2024 · Revista Foco
  96. Use of Modern Classification Systems for the Complex Diagnostics of Alzheimer’s Disease
    Yana Zorkina, Irina Morozova, Olga V. Abramova, Aleksandra Ochneva, O A Gankina, A. V. Andryushenko, M V Kurmyshev, Georgiy P. Kostyuk, Anna Y. Morozova · 2024 · Neuroscience and Behavioral Physiology
  97. Associations of Multimorbidity with Cerebrospinal Fluid Biomarkers for Neurodegenerative Disorders in Early Parkinson's Disease: A Crosssectional and Longitudinal Study
    Ming‐Zhan Zhang, Yan Ping Sun, Yanming Chen, Fan Guo, Pei‐Yang Gao, Lan Tan, Meng‐Shan Tan · 2024 · Current Alzheimer Research
  98. Parallel neuroinflammatory pathways to cerebrovascular injury and amyloid-beta in Alzheimer’s disease
    Batool M. Rizvi, Jenna N. Adams, Alison R. Bamford, Soyun Kim, Mithra T. Sathishkumar, Nicholas James Tustison, Lisa Taylor, Nandita Tuteja, Liv C. McMillan, Bin Nan et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Mesenchymal Cell-Derived Extracellular Vesicles Ameliorate Age-Related Deficits in Working Memory as well as Brain MRI and CSF in vivo Biomarkers of Neurodegeneration in Rhesus Monkeys
    Evan C. Mackie, Chia-Hsin Cheng, Maya N. Alibrio, Christine Rutledge, Hongqi Xin, Michael Chopp, Ryan McCann, Douglas L. Rosene, Qiong Yang, Ella Zeldich et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Effectively capturing memory deficits: New advances in the use of the In-out-Test for cognitive Test post-stroke
    Xiao Fei, Jing Zhang, Yue Shi, Jing Guo, Fan Xie, Yi Zhang · 2025 · Applied Neuropsychology Adult